Trial intelligence / Profile preview

Micardis HCT vs Diovan HCT in Hypertension

NCT00240448Phase 4Completed

Sponsor
Boehringer Ingelheim
Start
Sep 2003
Primary completion
Jun 2004
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of telmisartan in hypertension (HTN), sponsored by Boehringer Ingelheim. Started Sep 2003; status: completed.

02

Drugs

telmisartan
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT00240448.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00240448.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call